PERSPECTIVE ON ANTIPLATELET DRUGS

被引：2

|

作者：

OBRIEN, JR

机构：

来源：

SEMINARS IN THROMBOSIS AND HEMOSTASIS | 1989年 / 15卷 / 02期

关键词：

D O I：

10.1055/s-2007-1002701

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：171 / 172

页数：2

相关论文

共 50 条

[21] Antiplatelet Drugs in the Elderly
David Green
Paula Podrazik
Journal of Thrombosis and Thrombolysis, 2000, 9 : 115 - 116
[22] ANTIPLATELET DRUGS IN SECONDARY PREVENTION OF MYOCARDIAL-INFARCTION - CLINICAL RECOMMENDATIONS AND PERSPECTIVE IMPLICATIONS
LIBRETTI, A
BERTELE, V
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1989, 14 : S89 - S91
[23] Augmentation of thrombolysis with antiplatelet drugs
Coller, BS
CORONARY ARTERY DISEASE, 1995, 6 (12) : 911 - 914
[24] Antiplatelet drugs in cardiovascular diseases
Weston, C
Rao, U
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2003, 57 (10) : 898 - 905
[25] Clinical pharmacology of antiplatelet drugs
Gelbenegger, Georg
Jilma, Bernd
EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2022, 15 (10) : 1177 - 1197
[26] Antiplatelet drugs and the smokers' paradox
不详
AUSTRALIAN PRESCRIBER, 2015, 38 (04) : 112 - +
[27] Antiplatelet Drugs and Endothelial Function
Higashi, Yukihito
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2016, 23 (10) : 1147 - 1149
[28] Renal function and antiplatelet drugs
Keltai, Matyas M. D.
CORONARY ARTERY DISEASE: 2011 UPDATE: FROM PREVENTION TO INTERVENTION, 2011, : 263 - 268
[29] Antiplatelet drugs and liver fibrosis
Czajka, Pamela
Przybylkowski, Adam
Nowak, Anna
Postula, Marek
Wolska, Marta
Mirowska-Guzel, Dagmara
Czlonkowska, Anna
Eyileten, Ceren
PLATELETS, 2022, 33 (02) : 219 - 228
[30] ANTIPLATELET DRUGS - A COMPARATIVE REVIEW
SCHROR, K
DRUGS, 1995, 50 (01) : 7 - 28

← 1 2 3 4 5 →